279 related articles for article (PubMed ID: 6941373)
1. Interactions of cimetidine and pirenzepine on peptone-stimulated gastric acid secretion in man.
Londong W; Londong V; Prechtl R; Weber T; von Werder K
Scand J Gastroenterol Suppl; 1980; 66():103-14. PubMed ID: 6941373
[TBL] [Abstract][Full Text] [Related]
2. [Effectiveness of cimetidine, pirenzepine and synthetic secretin on stimulated gastric acid secretion].
Londong W; Londong V; Prechtl R; Schwanner A
Z Gastroenterol; 1980 Jun; 18(6):306-13. PubMed ID: 6893378
[TBL] [Abstract][Full Text] [Related]
3. Effects of cimetidine and pirenzepine on peroperative electrical vagal stimulation of gastric acid secretion.
Fritsch WP; Schacht U; Scholten T; Hengels KJ; Mueller J; Strasser K
Scand J Gastroenterol Suppl; 1980; 66():95-100. PubMed ID: 6941381
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of pirenzepine and cimetidine, alone and in combination, on 24-hour gastric acidity in duodenal ulcer disease.
Mahachai V; Reilly P; Thomson AB
Clin Ther; 1984; 7(1):98-111. PubMed ID: 6394132
[TBL] [Abstract][Full Text] [Related]
5. Complete inhibition of food-stimulated gastric acid secretion by combined application of pirenzepine and ranitidine.
Londong W; Londong V; Ruthe C; Weizert P
Gut; 1981 Jul; 22(7):542-8. PubMed ID: 6114900
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of vagal stimulated acid secretion by pirenzepine and cimetidine.
Scholten T; Fritsch WP; Müller JE; Hengels KJ
Scand J Gastroenterol Suppl; 1982; 72():169-71. PubMed ID: 6957986
[TBL] [Abstract][Full Text] [Related]
7. Simple approach to assess potentiated drug combinations in clinical trials: studies with pirenzepine plus H2-receptor antagonists.
Pöch G; Londong W
Int J Clin Pharmacol Ther Toxicol; 1985 Jun; 23(6):283-7. PubMed ID: 2862111
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of food stimulated acid secretion by association of pirenzepine and ranitidine in duodenal ulcer patients.
Lazzaroni M; Sangaletti O; Parente F; Imbimbo BP; Bianchi Porro G
Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):685-8. PubMed ID: 3818148
[TBL] [Abstract][Full Text] [Related]
9. A comparison of pirenzepine and cimetidine inhibition of centrally-mediated gastric acid and pepsin secretion in the gastric-fistula cat.
Browning JG; Heathcote BV
Arch Int Pharmacodyn Ther; 1983 Jun; 263(2):288-96. PubMed ID: 6411019
[TBL] [Abstract][Full Text] [Related]
10. The effect of a 100 mg pirenzepine--treatment on acid secretion and serum gastrin.
Fritsch WP; Scholten T; Müller J; Hengels KJ; Hanrath KD
Scand J Gastroenterol Suppl; 1982; 72():173-7. PubMed ID: 6957987
[TBL] [Abstract][Full Text] [Related]
11. The effect of pirenzepine on meal-stimulated gastric acid secretion, gastrin release and gastric emptying.
Bianchi Porro G; Prada A; Parente F; Sangaletti O; Lazzaroni M
Scand J Gastroenterol Suppl; 1982; 72():159-62. PubMed ID: 6957983
[TBL] [Abstract][Full Text] [Related]
12. Effects of pirenzepine and atropine on gastric secretory and plasma hormonal responses to sham-feeding in patients with duodenal ulcer.
Konturek SJ; Obtulowicz W; Kwiecień N; Dobrzańska M; Swierczek J; Kopp B; Olesky J
Scand J Gastroenterol Suppl; 1980; 66():63-9. PubMed ID: 6941379
[TBL] [Abstract][Full Text] [Related]
13. Effect of pirenzepine on L--amino acids stimulated gastric acid secretion and serum gastrin levels in peptic ulcer disease in men.
Bertoglio S; Anfossi A; Arnulfo G; Valentini P; Berti Riboli E
Scand J Gastroenterol Suppl; 1982; 72():179-84. PubMed ID: 6957988
[TBL] [Abstract][Full Text] [Related]
14. Modern approach to the evaluation of combined effects of single-dose trials and clinical time-course studies, exemplified by combinations of pirenzepine and H2-receptor antagonists.
Pöch G; Londong W
Int J Clin Pharmacol Ther Toxicol; 1993 Oct; 31(10):483-8. PubMed ID: 8262686
[TBL] [Abstract][Full Text] [Related]
15. Influence of atropine, pirenzepine and cimetidine on nocturnal gastro-intestinal motility and gastric acid secretion.
Lederer PC; Thiemann R; Femppel J; Domschke W; Lux G
Scand J Gastroenterol Suppl; 1982; 72():131-7. PubMed ID: 6957981
[TBL] [Abstract][Full Text] [Related]
16. Effect of pirenzepine and atropine on peptone meal-stimulated gastric secretion and plasma gastrin in healthy volunteers, patients with duodenal ulcer and vagotomized patients.
Lazzaroni M; Sangaletti O; Del Soldato P; Bianchi Porro G
Digestion; 1985; 32(4):267-72. PubMed ID: 3840755
[TBL] [Abstract][Full Text] [Related]
17. Effect of H2-receptor antagonists on gastric acid secretion and serum gastrin concentration: a review.
Richardson CT
Gastroenterology; 1978 Feb; 74(2 Pt 2):366-70. PubMed ID: 23338
[TBL] [Abstract][Full Text] [Related]
18. Anti-ulcer and secretion-inhibitory properties of the tricyclic derivative doxepin in rats and dogs.
Leitold M; Fleissig W; Merk A
Arzneimittelforschung; 1984; 34(4):468-73. PubMed ID: 6547610
[TBL] [Abstract][Full Text] [Related]
19. Antacids and anticholinergics in the treatment of duodenal ulcer.
Walan A
Clin Gastroenterol; 1984 May; 13(2):473-99. PubMed ID: 6086186
[TBL] [Abstract][Full Text] [Related]
20. Comparison between ranitidine, cimetidine, pirenzepine and placebo in the short term treatment of duodenal ulcer.
Giacosa A; Cheli R; Molinari F; Parodi MC
Scand J Gastroenterol Suppl; 1982; 72():215-9. PubMed ID: 6291138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
